CAS: 2051-07-2; 1,5-Bis(4-Methoxyphenyl)Penta-1,4-Dien-3-One

该化合物是有机化合物,其结构特征是五狄酮骨柱,由两种甲基苯基组替代,典型的黄色至橙色,以其在有机合成中的潜在应用和作为各种有机材料开发的一个构件而著称,具有显著的光学特性,使其在光化学和材料科学领域具有兴趣,甲基氧基组的存在增加了其在有机溶剂中的溶解性,并可能影响其与其他化学物种的再活动与互动.此外,五丁酮结构内的同系系统有助于其电子特性,可用于染料或光吸附材料等应用.与许多有机化合物一样,处理应谨慎,考虑到潜在的毒性和环境影响.

结构式图片

上下游产品

CAS号2573-84-4 2,6-双-(4-甲氧基苯基)... | CAS号33985-68-1 DIM-C-pPh°CH3 | CAS号89725-78-0 2,6-bis(4-metho... | CAS号5397-97-7 N-[(E,3E)-3-hyd...

合成工艺路线路线简述

    📜(2R,6S)-2,6-Bis(4-Methoxyphenyl)-1-Methylpiperidin-4-One置于selenium(Iv) Oxide,溶剂黄146体系中,化学反应 3.0H,以87%的收率获得(1E,4E)-1,5-双(4-甲氧基苯基)-1,4-戊二烯-3-酮
    参考文献:Vijayabaskar; Perumal; Muthusubramanian,Indian Journal Of Chemistry-Section B Organic And Medicinal Chemistry,1999,Vol. 38,# 8,P. 909-913
    标题:Vijayabaskar; Perumal; Muthusubramanian,Indian Journal Of Chemistry-Section B Organic And Medicinal Chemistry,1999,Vol. 38,# 8,P. 909-913

    海关参考信息

    专利信息


    专利号:US-11377396-B2
    优先权日:2014-12-18
    标题 :Enantioselective synthesis of α-quaternary Mannich adducts by palladium-catalyzed allylic alkylation
    发明人:STOLTZ BRIAN M; NUMAJIRI YOSHITAKA; PRITCHETT BEAU P; CHIYODA KOJI
    权利人:CALIFORNIA INST OF TECHN
    摘要:This invention provides enantioenriched Mannich adducts with quaternary stereogenic centers and novel methods of preparing the compounds. Methods include the method for the preparation of a compound of formula (I): n ncomprising treating a compound of formula (II):n n nwith a transition metal catalyst under alkylation conditions.

    专利号:WO-2011097717-A1
    优先权日:2010-02-15
    标 题 :Synthesis of bicyclic compounds and method for their use as therapeutic agents
    发明人:WULFF JEREMY EARLE; BRANT MICHAEL GLENN; BROMBA CALEB MATTHEW; BOULANGER MARTIN JOHN
    权利人:UNIV VICTORIA INNOVAT DEV; WULFF JEREMY EARLE; BRANT MICHAEL GLENN; BROMBA CALEB MATTHEW; BOULANGER MARTIN JOHN
    摘要:Disclosed embodiments concern the synthesis and use of therapeutic compounds that for treating emerging flu strains and minimizing resistance to such strains. Methods for making the disclosed compounds concern using a base-mediated addition/cyclization sequence followed by functional group manipulation to develop functionalized compounds that can target neuraminidase, which makes them ideal candidates for treating influenza. Pharmaceutical compositions comprising the therapeutic compounds and biologically-acceptable materials are also described. Methods of inhibiting neuraminidase in subjects that are suspected of containing neuraminidase are also described. The use of metabolites of the disclosed compounds can also be used in diagnostic assays for therapeutic dosing of the disclosed compounds.

    专利号:US-2020157020-A1
    优先权日:2014-12-18
    标题:Enantioselective synthesis of alpha-quaternary mannich adducts by palladium-catalyzed allylic alkylation

    专利号:US-2016176773-A1
    优先权日:2014-12-18
    标 题 :ENANTIOSELECTIVE SYNTHESIS OF alpha-QUATERNARY MANNICH ADDUCTS BY PALLADIUM-CATALYZED ALLYLIC ALKYLATION

    专利号:CN-101580491-A
    优先权日:2009-06-25
    标 题 :Microwave Synthesis of Fungicide Triaryl-2-Pyrazoline Derivatives

    专利号:CN-101580491-B
    优先权日:2009-06-25
    标 题 :Microwave Synthesis of Fungicide Triaryl-2-Pyrazoline Derivatives

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals., NX#02797
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知